Optilume Post Approval Clinical Evaluation of Andrology Parameters

Clinical Trial Information

Trial Phone: 321-841-7246

Principal Investigator: Lucas Wiegand, MD

Phase: IV

Age Group: ADULTOLDER_ADULT

ClinicalTrials.gov ID: NCT05383274

Objective

This study is measuring how sperm concentration changes over three months to evaluate the safety of the treatment.

Share:

Related Clinical Trials

Intracept Minimally-invasive Procedure for Vertebrogenic back pain
EndoZIP vs Apollo ESG
A Phase III, Randomized, Open-Label, Multicenter Study of Sacituzumab Tirumotecan (sac-TMT, MK-2870) Maintenance Treatment with or without Bevacizumab versus Standard of Care in Participants with Newly Diagnosed Advanced Non-HRD Positive Ovarian Cancer Following First-Line Platinum-Based Chemotherapy (TroFuse-021/ENGOT-ov85/GOG-3102)
Are Premature Infants with Bronchopulmonary Dysplasia Requiring Tracheostomy and Ventilation at Increased Risk of Atypical Craniosynostosis?